Research / Unapproved

Lypressin: Research Status and Trial Data

Drafted by an automated content engine from FDA, PubChem, ClinicalTrials.gov, NIH DSLD, and Open Beauty Facts data.

Molecular formulaC46H65N13O12S2
Molecular weight1056.2 g/mol
Registered trials86
PubChem CID644076

Lypressin turns up in searches about vasopressin-related peptides, but there is no approved drug label behind it in this dataset. Here is what the available identity and trial records actually show.

What Lypressin Is

Lypressin is a peptide compound with the molecular formula C46H65N13O12S2 and a molecular weight of about 1,056 daltons (PubChem CID 644076). No FDA-approved product label is associated with this compound in the data reviewed, so there is no confirmed indication, mechanism description, or brand name to report.

Trial Footprint

Registry records show 86 clinical trials associated with this compound's identifier. Among the sampled records, one completed trial addressed type 2 hepatorenal syndrome, another completed trial examined septic shock in patients with cirrhosis, and a separate completed trial compared two dental anesthetics for tooth extraction. These entries describe registered study activity only and do not establish that lypressin itself is effective or approved for any use.

FAQ

Is lypressin FDA-approved?
No approved FDA label for lypressin appears in the data reviewed here. Without a label, there are no confirmed approved indications, dosing information, or official brand names to report.
What kind of compound is lypressin?
Lypressin is a peptide with the molecular formula C46H65N13O12S2 and a molecular weight of roughly 1,056 daltons. It is catalogued under PubChem CID 644076.
How many clinical trials involve lypressin?
Registry data lists 86 clinical trials tied to this compound's identifier. Sampled trials include studies in hepatorenal syndrome, septic shock in cirrhosis, and a dental anesthesia comparison.
Does research trial activity mean lypressin works for these conditions?
No. Registered trials show that studies have been conducted or completed, but they do not by themselves prove safety or effectiveness. Trial status such as 'completed' refers only to the study timeline, not to a confirmed outcome or approval.
Are there reported side effects for lypressin?
No adverse event report data was available in the dataset used for this overview. This does not mean side effects do not exist, only that no such records were provided here.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication. Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.

Sources: PubChem ClinicalTrials.gov

Updated 2026-08-04